Association between Lymphocyte Monocyte Ratio and Clinical Staging of Nasopharyngeal Carcinoma
Keywords:Nasopharyngeal cancer, clinical stage, lymphocyte monocyte ratio
Nasopharyngeal cancer (NPC) is the most common head and neck malignancy with an ever-increasing incidence. Inflammatory biomarkers has been proven to be an indicator of immune response against malignancies. A more advanced clinical stage will elicit a worse immune response against tumor cells. A simple and low cost laboratory examination using biomarkers such as lymphocyte monocyte ratio is needed in order to determine the prognosis of NPC patients based on immune response against malignancies.
Objective: To determine the association between lymphocyte monocyte ratio and the clinical stage of patients with NPC.
A case control study was used on data obtained from medical records of NPC patients who had undergone staging in the Otolaryngology Outpatient Department of Sardjito Public Hospital from 2015 to 2018.
Total of 64 patients were enrolled in the study, comprising of 38 males (59.4%) and 26 females (40.6%). There were 33 (51.6%) patients aged ≤ 50 years and 31 patients (48.4%) aged > 50 years, with early and advanced clinical stages of 32 patients in each age group. The most common histopathological type is undifferentiated carcinoma (WHO Type 3) (60 patients, 93.7%) followed by non-keratinizing carcinoma (WHO Type 2) (4 patients, 6.3%). The cutoff ratio for lymphocyte monocyte ratio was obtained from ROC Curve analysis, which was 2,64. Statistical analysis using chi-square test showed an association between LMR and clinical staging of NPC patients with a p value < 0,001, with an Odds Ratio of 6.53 (CI 95%; 2.19 – 19.42). Thus, patients with a lower LMR was shown to have 6.53 times the risk of having a more advanced clinical stage compared to higher LMR.
There was found to be an association between lymphocyte monocyte ratio and clinical staging of nasopharyngeal cancer patients
Wei WI, Chua DTT. Nasopharyngeal Carcinoma. Dalam: Eibling DE & Newlands SD, editor. Bailey’s Head and Neck Surgery Otolaryngology. 2014; 5: 1875-97.
Adham M., Kurniawan AN, Muhtadi AI, Roezin A, Hermani B, Gondhowiardjo S, Tan IB, and Middeldorp JM .'Nasopharyngeal carcinoma in Indonesia: epidemiology, incidence, signs, and symtoms at presentation', Chinese Journal of Cancer. 2012; 185–96. DOI: https://doi.org/10.5732 / cjc.011.10328
Hutajulu SH, Indrasari SR, Indrawati LPL, Harijadi A, Duin S, Haryana SM, Steenbergen RDM, Greijer AE and Middeldorp JM. ‘Epigenetic markers for early detection of nasopharyngeal carcinoma in a high risk population’, Molecular Cancer. BioMed Central Ltd. 2011; 10(1): 48. DOI: https://doi.org/10.1186/1476-4598-10-48
Fachiroh J, Prasetyanti PR, Paramita DK, Prasetyawati AT, Anggrahini DW, Haryana SM and Middeldorp JM.Dried-blood sampling for epstein- barr virus immunoglobulin G (IgG) and IgA serology in nasopharyngeal carcinoma screening, Journal of Clinical Microbiology. 2008; 46(4) : 1374–80. DOI: https://doi.org/10.1128 / JCM.01368-07
Yousefi MS., Sharifi-Esfahani M, Pourgholam-Amiji N, Afshar M, Sadeghi-Gandomani H, Otroshi O. and Salehiniya H. Esophageal cancer in the world: incidence, mortality and risk factors, Biomedical Research and Therapy; 2018: 5(7): 2504–17. DOI: https://doi.org/ 10.15419/bmrat.v5i7.460
Guthrie GJK, Charles KA., Roxburgh CSD, Horgan PG., Mcmillan DC. and Clarke SJ..The systemic inflammation-based neutrophil – lymphocyte ratio : Experience in patients with cancer, Critical Reviews in Oncology/ Hematology. Elsevier Ireland Ltd. 2013; 88(1): 218–30. DOI: https://doi.org/10.1016/j.critrevonc.2013.03.010
Tham T, Olson C, Khaymovich J, Herman SW and Costantino PD. The lymphocyte-to-monocyte ratio as a prognostic indicator in head and neck cancer: a systematic review and meta-analysis, European Archives of Oto-Rhino- Laryngology. Springer Berlin Heidelberg. 2018; 275(7): 1663–70. DOI: https://doi.org/10.1007/s00405-018-4972-x
Ostuni R, Kratochvill F, Murray P J and Natoli G. Macrophages and cancer: From mechanisms to therapeutic implications, Trends in Immunology. Elsevier Ltd. 2015; 36(4) : 229–39. DOI: https://doi.org/10.1016/j.it.2015.02.004
Lin JC, Wang WY, Chen KY. Quantification of plasma Epstein– Barr virus DNA in patients with advanced nasopharyngeal carcinoma. N Engl J Med. 2014; 350:2461–70. DOI: https://doi.org/10.1056/NEJMoa032260
Zhu J, yu Liu C, cheng Wang L, Zhong M, Tang H, lin, et al. Peripheral blood lymphocyte-to-monocyte ratio as a prognostic factor in advanced epithelial ovarian cancer: A multicenter retrospective study. Journal of Cancer. 2017 8(5), pp. 737–743. DOI: https://doi.org/10.7150/jca.17668
Teng JJ, Zhang J, Zhang TY, Zhang S, Li BS. Prognostic value of peripheral blood lymphocyte-to-monocyte ratio in patients with solid tumors: A metaanalysis. OncoTargets and Therapy. 2015. 9, pp. 37–47. DOI: https://doi.org/10.2147/OTT.S94458
Lee SF, Ng TY, Spika D. Prognostic value of lymphocyte-monocyte ratio at diagnosis in Hodgkin lymphoma: A meta-analysis. BMC Cancer. BMC Cancer. 2019. 19(1), pp. 1–12. DOI: https://doi.org/10.1186/s12885-019-5552-1
Zhang GM, Zhu Y, Luo L, Wan FN, Zhu Y P, Sun LJ, et al. Preoperative lymphocyte-monocyte and platelet-lymphocyte ratios as predictors of overall survival in patients with bladder cancer undergoing radical cystectomy. Tumor Biology. 2015. 36(11), pp. 8537–8543. DOI: https://doi.org/10.1007/s13277-015-3613-x
Liu X, Li M, Zhao F, Zhu Y, Luo Y, Kong L, et al. The lymphocyte–monocyte ratio predicts tumor response and survival in patients with locally advanced esophageal cancer who received definitive chemoradiotherapy. OncoTargets and Therapy. 2017. 10, pp. 871–877. DOI: https://doi.org/10.2147 / OTT.S124915
Jiang Y, Qu S, Pan X, Huang S, Zhu X. Prognostic value of neutrophil-to-lymphocyte ratio and plateletto- lymphocyte ratio in intensity modulated radiation therapy for nasopharyngeal carcinoma. Oncotarget. 2018;9(11):9992–10004. DOI: https://doi.org/10.18632/oncotarget.24173
Iwahori K, Shintani Y, Funaki S, Yamamoto Y, Matsumoto M, Yoshida T, et al. Peripheral T cell cytotoxicity predicts T cell function in the tumor microenvironment. Scientific Reports. 2019. 9(1), pp. 2005–2008. DOI: https://doi.org/10.1038/s41598-019-39345-5
Xie SH, Yu ITS, Tse LA, Mang OWK, Yue L. Sex difference in the incidence of nasopharyngeal carcinoma in Hong Kong 1983-2008: Suggestion of a potential protective role of oestrogen. European Journal of Cancer. 2013; 49(1), pp. 150–155. DOI: https://doi.org/10.1016/j.ejca.2012.07.004
Ouyang PY, Zhang LN, Lan XW, Xie C, Zhang WW, Wang QX, et al. The significant survival advantage of female sex in nasopharyngeal carcinoma: A propensity-matched analysis. British Journal of Cancer. 2015; 112(9), pp. 1554–1561. DOI: https://doi.org/10.1038/bjc.2015.70
Meng X, Chang Q, Liu Y, Chen L, Wei G, Yang J, et al. Determinant roles of gender and age on SII, PLR, NLR, LMR and MLR and their reference intervals defining in Henan, China: A posteriori and big-data based. Journal of Clinical Laboratory Analysis. 2018; 32(2), pp. 1–8. DOI: https://doi.org/10.1002/jcla.22228
Huang D, Song SJ, Wu ZZ, Wu W, Cui XY, Chen JN, et al. Epstein-Barr virus-induced VEGF and GM-CSF drive nasopharyngeal carcinoma metastasis via recruitment and activation of macrophages. Cancer Research. 2017; 77(13), pp. 3591–3604. DOI: 10.1158/0008-5472.CAN-16-2706
How to Cite
Copyright (c) 2021 INTERNATIONAL JOURNAL OF NASOPHARYNGEAL CARCINOMA
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The Authors submitting a manuscript do so on the understanding that if accepted for publication, copyright of the article shall be assigned to The International Journal of Nasopharyngeal Carcinoma (IJNPC) as well as TALENTA Publisher Universitas Sumatera Utara as publisher of the journal.
Copyright encompasses exclusive rights to reproduce and deliver the article in all form and media. The reproduction of any part of this journal, its storage in databases and its transmission by any form or media, will be allowed only with a written permission from The International Journal of Nasopharyngeal Carcinoma (IJNPC).